ICD-10 Code D10.6: Benign neoplasm of nasopharynx

Key Takeaways

D10.6 is a billable ICD-10-CM code for benign neoplasm of nasopharynx, valid for FY2026 HIPAA-covered transactions (October 1, 2025 through September 30, 2026).

D10.6 is classified under Chapter 2: Neoplasms (C00-D49), block D10-D36, and includes benign neoplasm of the nasopharyngeal surface of soft palate.

Never use D10.6 for malignant nasopharyngeal tumors; those require C11.x codes. Misclassification creates significant billing and clinical risk.

Pabau’s claims management software and clinical documentation tools help ENT and head-and-neck practices capture D10.6 accurately and reduce claim errors.

ICD-10 Code D10.6 is the billable ICD-10-CM diagnosis code for benign neoplasm of nasopharynx. It is valid for HIPAA-covered transactions for FY2026, covering the period October 1, 2025 through September 30, 2026.

The code is maintained jointly by the Centers for Medicare and Medicaid Services (CMS) and the National Center for Health Statistics (NCHS) under the authority of the World Health Organization’s international classification framework. Pabau’s claims management software helps practices capture diagnosis codes accurately at the point of documentation.

ICD-10 Code D10.6: Definition and clinical description

The nasopharynx is the upper portion of the pharynx, situated behind the nasal cavity and above the soft palate. Benign neoplasms in this region are non-cancerous growths, most commonly including juvenile nasopharyngeal angiofibromas, polyps, and adenoid hypertrophy presenting as neoplastic tissue. D10.6 captures all histologically confirmed benign neoplasms arising from this anatomical zone, including the nasopharyngeal surface of the soft palate and structures such as the posterior margin of the nasal septum, the choanae, and tissue near the Eustachian tube opening.

Classification hierarchy for ICD-10 Code D10.6

D10.6 sits within a clearly defined hierarchical structure in the ICD-10-CM tabular list. Understanding the hierarchy matters because parent and sibling codes determine sequencing rules and crosswalk options during coding review.

The parent category D10 covers all benign neoplasms of the mouth and pharynx. Within that category, codes are assigned by anatomical sub-site: lip (D10.0), tongue (D10.1), floor of mouth (D10.2), other and unspecified parts of mouth (D10.3), tonsil (D10.4), other parts of oropharynx (D10.5), nasopharynx (D10.6), hypopharynx (D10.7), and unspecified pharynx (D10.9). D10.6 is the only code in the D10 category that specifically addresses the nasopharyngeal sub-site, making it the correct billable code whenever a confirmed benign nasopharyngeal neoplasm is the primary or secondary diagnosis.

For coders working across multiple specialties, these ICD-10-CM diagnosis codes follow the same hierarchical logic throughout the Chapter 2 classification, where specificity always takes precedence over category-level codes. The WHO ICD-10 browser provides the complete hierarchical view for reference.

Inclusion terms and approximate synonyms

Inclusion terms define the clinical presentations that D10.6 legitimately captures. Coders should confirm that the documented diagnosis matches one of these terms before assigning the code.

• Benign neoplasm of nasopharyngeal surface of soft palate (explicitly included under D10.6)
• Benign neoplasm of the adenoid (pharyngeal tonsil) when arising in the nasopharynx
• Benign neoplasm of the posterior margin of the nasal septum and choanae
• Benign neoplasm of the Eustachian tube orifice (nasopharyngeal aspect)
• Nasopharyngeal polyp classified as a benign neoplasm on pathology
• Juvenile nasopharyngeal angiofibroma (confirmed benign on biopsy)

Approximate synonyms commonly found in clinical notes that map to D10.6 include: nasopharyngeal fibroma, nasopharyngeal papilloma, benign nasopharyngeal tumor, and benign nasopharyngeal growth. When the pathology report uses these terms and confirms benign histology, D10.6 is the correct ICD-10-CM assignment. Coders relying on clinical notes alone should request pathology confirmation before finalizing the code, particularly when the documentation uses non-specific language such as “nasopharyngeal mass” or “nasopharyngeal lesion.”

D10.6 vs. related codes: choosing the right diagnosis

The most clinically significant distinction in this code range is between D10.6 and the C11.x series. Misclassifying a malignant nasopharyngeal carcinoma as a benign neoplasm creates downstream clinical and billing problems that can take months to resolve. In this code range, specificity and confirmed histology always determine the correct selection.

The ICD-10-CM chapter structure definitively separates benign neoplasms (D10-D36) from malignant neoplasms (C00-C96). There is no overlap. Once pathology confirms malignancy, the C11.x series applies regardless of the anatomical sub-site within the nasopharynx. D10.9 (pharynx, unspecified) is a fallback for genuinely undocumented sub-site location, but coders should query the treating clinician for specificity before defaulting to the unspecified code.

Clinical documentation requirements for D10.6

Accurate documentation is what separates a clean claim from a denial. For D10.6, payers expect the clinical record to support the diagnosis at three levels: anatomical specificity, histological confirmation, and clinical management context.

Anatomical specificity

The clinical note or operative report must identify the nasopharynx as the site of the neoplasm. Vague language such as “posterior pharyngeal mass” or “upper airway growth” without anatomical localization is insufficient. ENT documentation should reference specific landmarks: the nasopharyngeal vault, posterior choanae, adenoid bed, Eustachian tube orifice, or the nasopharyngeal surface of the soft palate.

Histological confirmation

Payers processing claims for neoplasm codes generally expect pathology-confirmed diagnoses. A biopsy or surgical excision specimen report confirming benign histology (such as fibroma, papilloma, or angiofibroma) substantiates D10.6 assignment.

When a biopsy has not yet been performed, coders may use D10.6 based on the treating clinician’s documented clinical impression, provided the note clearly states the lesion is being managed as a benign neoplasm. However, once pathology returns, the code should be reviewed and updated if the histological finding conflicts with the initial clinical impression.

Clinical management context

The record should document how the neoplasm is being managed: active surveillance, endoscopic excision, radiation planning review, or post-operative follow-up. Payers use this context to validate that the coded diagnosis aligns with the service being billed. An office visit coded for D10.6 alongside a CPT code for nasal endoscopy makes clinical sense. The same diagnosis paired with a chemotherapy administration code would trigger a medical necessity review.

Pabau’s clinical documentation tools help practices structure encounter notes to capture all three documentation elements consistently, supporting accurate code assignment and reducing patient data security risks associated with incomplete records.

Streamline ENT coding and documentation with Pabau

Pabau's all-in-one practice management software helps ENT and head-and-neck practices capture diagnosis codes accurately, structure clinical notes for audit compliance, and reduce claim errors across billing workflows.

Book a demo

Common procedures associated with D10.6

When D10.6 appears on a claim, it is typically paired with CPT procedure codes for evaluation or surgical management of the nasopharyngeal neoplasm. Knowing which CPT codes commonly accompany D10.6 helps coders validate claim combinations and anticipate payer scrutiny.

• CPT 92511 (Nasopharyngoscopy with endoscope): The most common diagnostic procedure code paired with D10.6. Used for direct visualization of the nasopharynx during evaluation visits.
• CPT 42890 (Limited pharyngectomy): Occasionally applicable when surgical excision of a nasopharyngeal benign neoplasm is performed, depending on the extent of resection.
• CPT 31295-31296 (Nasal/sinus endoscopy with balloon dilation): May apply in cases where nasopharyngeal access requires concurrent nasal endoscopic techniques.
• CPT 88305 (Level IV surgical pathology): Applied when the excised neoplasm is submitted for histological examination to confirm benign classification.
• CPT 70543 / 70553 (MRI of head without/with contrast): Imaging codes that commonly precede or accompany D10.6 when radiological workup is needed to characterize the lesion extent.

Payers apply medical necessity criteria when reviewing D10.6 claims. Nasal endoscopy codes are generally accepted alongside D10.6 for initial evaluation and surveillance. Surgical excision codes trigger greater scrutiny, and documentation should clearly state the clinical indication for resection (airway obstruction, recurrence, diagnostic uncertainty, or symptomatic progression).

Coding guidelines and payer considerations

CMS and NCHS publish the ICD-10-CM Official Guidelines for Coding and Reporting annually. Several general guidelines from Chapter 2 apply directly to D10.6 claims.

Sequencing as principal versus secondary diagnosis

When the patient presents specifically for management of the benign nasopharyngeal neoplasm (evaluation, excision, or follow-up), D10.6 is sequenced as the principal diagnosis. When the neoplasm is an incidental finding during an encounter for a different condition, D10.6 is sequenced as a secondary diagnosis after the primary reason for the visit. The CDC/NCHS ICD-10-CM web tool is the authoritative source for confirming sequencing rules and valid code-year combinations.

Excludes notes

D10.6 carries no Type 1 Excludes notes that prohibit it from being reported alongside specific other codes. However, the ICD-10-CM chapter structure creates a functional exclusion: codes from the malignant neoplasm range (C11.x) cannot be reported simultaneously with D10.6 for the same anatomical site. If pathology demonstrates carcinoma, the D10.6 code must be replaced, not supplemented, by the appropriate C11.x code. The compliance management tools built into practice management platforms help flag inconsistent code combinations before claims are submitted.

Uncertainty and “rule out” scenarios

ICD-10-CM guidelines for outpatient encounters specify that “rule out” or “suspected” diagnoses should not be coded as confirmed. If the clinician documents “rule out nasopharyngeal neoplasm” or “suspected benign nasopharyngeal mass,” coders should assign the sign or symptom code that prompted the workup (such as R09.89 for other specified symptoms involving the respiratory system) rather than D10.6. D10.6 is only appropriate once the clinician has confirmed the diagnosis.

Billing and reimbursement workflow for ICD-10 Code D10.6 claims

Claims denials for D10.6 most often trace back to three workflow failures: incomplete documentation at the encounter, a mismatch between the procedure code and the diagnosis, or a code validity error where an outdated fiscal year code is submitted. Addressing all three requires a systematic pre-submission workflow.

• Step 1: Confirm code validity for the encounter date. D10.6 is valid for HIPAA-covered transactions from October 1, 2025 through September 30, 2026 (FY2026). For encounters before October 1, 2025, verify the code was also valid in the applicable fiscal year using the CMS ICD-10 codes page.
• Step 2: Validate anatomical documentation. Review the clinical note before coding. Confirm the nasopharynx is identified as the site and that the documentation supports benign classification (pathology report or clinician’s clinical impression).
• Step 3: Cross-check the CPT-to-ICD-10 pairing. Confirm the procedure code is clinically consistent with a benign nasopharyngeal neoplasm. Imaging, endoscopy, and surgical pathology codes are expected pairings. Chemotherapy or radiation administration codes require additional medical necessity documentation.
• Step 4: Review payer-specific policies. Some Medicare Administrative Contractors and commercial payers have Local Coverage Determinations (LCDs) or Medical Coverage Policies that specify documentation requirements for neoplasm-related claims. Check the payer’s portal before submission.
• Step 5: Submit and track. Document the submission date, payer, and claim reference. Track denial patterns by code pair to identify recurring documentation issues that can be corrected upstream at the clinical note stage.

Practices using structured digital intake forms that capture presenting complaints and referral diagnoses at intake reduce the risk of documentation errors reaching the billing stage. When the diagnosis field is completed at intake and linked to the clinical note template, coders have a consistent starting point for validating the ICD-10 code assignment. For a broader view of how EHR for private practice supports accurate coding workflows, Pabau’s platform connects intake documentation directly to billing output.

Conclusion

Benign nasopharyngeal neoplasms are relatively uncommon, but the coding errors that follow inaccurate D10.6 assignment are not. The distinction between benign (D10.6) and malignant (C11.x) is the single highest-stakes decision in this code range, and it must be driven by pathology, not clinical intuition alone.

Pabau’s all-in-one practice management software gives ENT and head-and-neck practices the documentation structure and billing workflow tools to capture D10.6 accurately, reduce claim denials, and maintain audit-ready records. To see how Pabau handles diagnosis coding workflows across multi-specialty practices, book a demo.

Expert picks

Continue your research

Need to understand how clinical notes connect to billing accuracy? Safer clinical notes covers the documentation standards that reduce audit risk and support accurate ICD-10 coding across specialties.

Managing a multi-specialty practice with complex coding needs? EHR integration explains how connected systems reduce manual coding errors and improve claim accuracy across clinical teams.

Want a structured approach to compliance documentation? Medical spa compliance checklist outlines the documentation and audit trail requirements that apply across billing-intensive clinical settings.

Frequently asked questions